Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

549

Participants

Timeline

Start Date

October 23, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage II Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8Hematopoietic and Lymphoid Cell NeoplasmInvasive Malignant NeoplasmLeukemiaLymphomaMalignant Solid NeoplasmSarcomaStage I Colorectal Cancer AJCC v8Stage II Colorectal Cancer AJCC v8Stage III Colorectal Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Thyroid Gland Carcinoma
Interventions
OTHER

Internet Mobile Technology

Use INSPIRE mobile application

OTHER

Internet-Based Intervention

Access to a study-specific control website

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Supportive Care

Receive telehealth stepped care

OTHER

Informational Intervention

Receive printed SCP materials

Trial Locations (5)

10065

Memorial Sloan Kettering Cancer Center, New York

19104

University of Pennsylvania/Abramson Cancer Center, Philadelphia

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

02215

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER